跳至主要内容
临床试验/EUCTR2016-004764-18-IE
EUCTR2016-004764-18-IE进行中(未招募)1 期

Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial - Karma-dep trial

St Patrick’s Mental Health Services0 个研究点目标入组 25 人开始时间: 2016年11月30日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • =18 years old
  • Hamilton Rating Scale for Depression-24 item version (HRSD-24) score of =21
  • Voluntary admission for treatment of an acute depressive episode
  • Meet DSM-IV criteria for a major depressive disorder (MDD) and bipolar affective disorder (current episode depression)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Current involuntary admission
  • Medical condition rendering unfit for ketamine/midazolam
  • Active suicidal intention
  • History of Axis 1 diagnosis other than major depression
  • Electroconvulsive Therapy (ECT) administered within the last two months
  • Alcohol/substance dependence in previous six-months
  • Pregnancy or inability to confirm use of adequate contraception during the trial

研究者

发起方
St Patrick’s Mental Health Services

相似试验